SEC
|
Ferguson Toby
|
Chief Medical Officer
|
|
-19K
|
$3.73
|
-$70.87K
|
|
SEC
|
Ferguson Toby
|
Chief Medical Officer
|
|
-10K
|
$3.43
|
-$34.59K
|
|
SEC
|
Sandrock Alfred
|
President and CEO
|
|
-11K
|
$3.43
|
-$37.34K
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-3.3K
|
$4.26
|
-$14.08K
|
|
SEC
|
Sandrock Alfred
|
President and CEO
|
|
-12K
|
$4.24
|
-$49.62K
|
|
SEC
|
Swartz Robin
|
COO & CBO
|
|
-3.9K
|
$4.25
|
-$16.55K
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-5.4K
|
$4.45
|
-$24.09K
|
|
SEC
|
Fahey Sandell Jacquelyn
|
Chief Legal Officer
|
|
-4.4K
|
$4.45
|
-$19.39K
|
|
SEC
|
Sandrock Alfred
|
President & CEO
|
|
-17K
|
$4.45
|
-$74.07K
|
|
SEC
|
Swartz Robin
|
COO & CBO
|
|
-7K
|
$4.45
|
-$30.93K
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-1.2K
|
$5.13
|
-$6.11K
|
|
SEC
|
Swartz Robin
|
COO & CBO
|
|
-3.1K
|
$5.09
|
-$15.71K
|
|
SEC
|
Swartz Robin
|
COO&CBO
|
|
-6.5K
|
$5.65
|
-$36.73K
|
|
SEC
|
Fahey Sandell Jacquelyn
|
Chief Legal Officer
|
|
-6K
|
$5.82
|
-$34.91K
|
|
SEC
|
Sandrock Alfred
|
President and CEO
|
|
-12K
|
$9.86
|
-$119.45K
|
|
SEC
|
Swartz Robin
|
Chief Operating Officer
|
|
-1.4K
|
$9.88
|
-$13.41K
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-4K
|
$7.50
|
-$29.75K
|
|
SEC
|
PFREUNDSCHUH PETER P.
|
Chief Financial Officer
|
|
-3.8K
|
$7.46
|
-$28.08K
|
|
SEC
|
Sandrock Alfred
|
President and CEO
|
|
-13K
|
$7.46
|
-$97.23K
|
|
SEC
|
Swartz Robin
|
Chief Operating Officer
|
|
-4K
|
$7.45
|
-$29.55K
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-1.3K
|
$7.18
|
-$9.09K
|
|
SEC
|
Swartz Robin
|
Chief Operating Officer
|
|
-2.5K
|
$7.15
|
-$18.18K
|
|
SEC
|
PFREUNDSCHUH PETER P.
|
Chief Financial Officer
|
|
-14K
|
$6.99
|
-$94.83K
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-11K
|
$8.16
|
-$85.68K
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-5.5K
|
$10.80
|
-$59.40K
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-5K
|
$11.41
|
-$57.05K
|
|
SEC
|
Sandrock Alfred
|
President and CEO
|
|
-7.4K
|
$7.83
|
-$58.23K
|
|
SEC
|
Swartz Robin
|
Chief Operating Officer
|
|
-1.3K
|
$7.83
|
-$9.86K
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-2.2K
|
$7.76
|
-$17.02K
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
-4.4K
|
$7.76
|
-$34.22K
|
|
SEC
|
Swartz Robin
|
Chief Operating Officer
|
|
-3.7K
|
$7.76
|
-$28.36K
|
|
SEC
|
Swartz Robin
|
Chief Operating Officer
|
|
-15K
|
$8.20
|
-$126.06K
|
|
SEC
|
NEUROCRINE BIOSCIENCES INC
|
N/A
|
|
+4.4M
|
$8.88
|
+$39.03M
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-738
|
$7.45
|
-$5.50K
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
-3.3K
|
$7.45
|
-$24.56K
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-797
|
$7.67
|
-$6.11K
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
-2.9K
|
$7.67
|
-$22.00K
|
|
SEC
|
TEPPER ROBERT I
|
N/A
|
|
-389K
|
$9.23
|
-$3.59M
|
|
SEC
|
TEPPER ROBERT I
|
N/A
|
|
-50K
|
$9.02
|
-$451.00K
|
|
SEC
|
TEPPER ROBERT I
|
N/A
|
|
-150K
|
$9.25
|
-$1.39M
|
|
SEC
|
TEPPER ROBERT I
|
N/A
|
|
-155K
|
$9.12
|
-$1.41M
|
|
SEC
|
Carter Todd Alfred
|
Chief Scientific Officer
|
|
-1.1K
|
$9.85
|
-$10.89K
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
-2.2K
|
$9.85
|
-$21.55K
|
|
SEC
|
Swartz Robin
|
Chief Operating Officer
|
|
-2.2K
|
$9.85
|
-$21.55K
|
|
SEC
|
EcoR1 Capital, LLC
|
N/A
|
|
-902K
|
$7.91
|
-$7.14M
|
|
SEC
|
TEPPER ROBERT I
|
N/A
|
|
-350K
|
$6.16
|
-$2.16M
|
|
SEC
|
TEPPER ROBERT I
|
N/A
|
|
-128K
|
$6.04
|
-$775.87K
|
|
SEC
|
TEPPER ROBERT I
|
N/A
|
|
-484K
|
$6.10
|
-$2.95M
|
|
SEC
|
Higgins Michael J
|
N/A
|
|
-14K
|
$6.70
|
-$93.07K
|
|
SEC
|
PIERCE GLENN
|
N/A
|
|
-9.5K
|
$6.70
|
-$63.73K
|
|
SEC
|
EcoR1 Capital, LLC
|
N/A
|
|
+477K
|
$5.58
|
+$2.66M
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
-2.8K
|
$8.25
|
-$22.98K
|
|
SEC
|
Swartz Robin
|
Chief Operating Officer
|
|
-1.5K
|
$8.25
|
-$12.60K
|
|
SEC
|
Burek Julie
|
VP, Finance
|
|
-2.6K
|
$8.29
|
-$21.96K
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
-5K
|
$8.29
|
-$41.08K
|
|
SEC
|
Swartz Robin
|
Chief Operating Officer
|
|
-4.4K
|
$8.29
|
-$36.58K
|
|
SEC
|
Burek Julie
|
VP, Finance
|
|
-789
|
$3.55
|
-$2.80K
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
-4.1K
|
$3.55
|
-$14.56K
|
|
SEC
|
Burek Julie
|
VP, Finance
|
|
-361
|
$3.36
|
-$1.21K
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
-3.3K
|
$3.36
|
-$10.93K
|
|
SEC
|
Burek Julie
|
VP, Finance
|
|
-265
|
$2.59
|
-$686.35
|
|
SEC
|
Khwaja Omar
|
See remarks
|
|
-3.5K
|
$4.03
|
-$14.17K
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
+3.3K
|
$4.95
|
+$16.30K
|
|
SEC
|
Dorval Allison
|
Chief Financial Officer
|
|
-3.2K
|
$7.55
|
-$24.05K
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
-3.2K
|
$7.55
|
-$24.05K
|
|
SEC
|
Khwaja Omar
|
See remarks
|
|
-3.5K
|
$7.55
|
-$26.24K
|
|
SEC
|
Turenne Andre
|
President & CEO
|
|
-8K
|
$7.55
|
-$60.23K
|
|
SEC
|
Dorval Allison
|
Chief Financial Officer
|
|
-2.9K
|
$8.62
|
-$25.36K
|
|
SEC
|
Turenne Andre
|
President & CEO
|
|
-10K
|
$8.62
|
-$90.02K
|
|
SEC
|
Khwaja Omar
|
See remarks
|
|
-3.5K
|
$12.96
|
-$45.36K
|
|
SEC
|
Hesslein Robert W.
|
Senior VP & General Counsel
|
|
-3.1K
|
$8.51
|
-$26.30K
|
|
SEC
|
Dorval Allison
|
Chief Financial Officer
|
|
-3.1K
|
$13.36
|
-$41.79K
|
|
SEC
|
Ottmer Matthew P.
|
Chief Operating Officer
|
|
-3.7K
|
$13.36
|
-$49.75K
|
|
SEC
|
Turenne Andre
|
President & CEO
|
|
-11K
|
$13.36
|
-$143.02K
|
|
SEC
|
NEUROCRINE BIOSCIENCES INC
|
N/A
|
|
+4.2M
|
$11.96
|
+$49.99M
|
|
SEC
|
PIERCE GLENN
|
N/A
|
|
+5K
|
$18.44
|
+$92.20K
|
|
SEC
|
GERAGHTY JAMES A
|
N/A
|
|
+3K
|
$19.39
|
+$58.17K
|
|
SEC
|
GERAGHTY JAMES A
|
N/A
|
|
+3K
|
$18.31
|
+$54.93K
|
|
SEC
|
Ravina Bernard
|
Chief Medical Officer
|
|
-2.5K
|
$18.38
|
-$45.05K
|
|
SEC
|
Ravina Bernard
|
Chief Medical Officer
|
|
-2.5K
|
$25.16
|
-$61.67K
|
|
SEC
|
Sah Dinah Ph.D.
|
Chief Scientific Officer
|
|
-31K
|
$19.99
|
-$624.61K
|
|
SEC
|
Ravina Bernard
|
Chief Medical Officer
|
|
-2.5K
|
$18.24
|
-$44.71K
|
|
SEC
|
Ravina Bernard
|
Chief Medical Officer
|
|
-3.6K
|
$16.40
|
-$59.53K
|
|
SEC
|
Ravina Bernard
|
Chief Medical Officer
|
|
-5.5K
|
$13.63
|
-$74.83K
|
|
SEC
|
Ravina Bernard
|
Chief Medical Officer
|
|
-5.5K
|
$13.26
|
-$72.80K
|
|
SEC
|
Ravina Bernard
|
Chief Medical Officer
|
|
-11K
|
$20.33
|
-$223.22K
|
|
SEC
|
Ravina Bernard
|
Chief Medical Officer
|
|
-16K
|
$12.87
|
-$211.97K
|
|
SEC
|
Ravina Bernard
|
Chief Medical Officer
|
|
-5.5K
|
$10.00
|
-$54.90K
|
|
SEC
|
PAUL STEVEN M
|
President and CEO
|
|
+10K
|
$14.07
|
+$140.70K
|
|
SEC
|
Sanofi
|
N/A
|
|
+125K
|
$14.00
|
+$1.75M
|
|